Solitary fibrous tumors of the head and neck region revisited: a single-institution study of 20 cases and review of the literature.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
05 2020
Historique:
received: 23 01 2020
revised: 07 03 2020
accepted: 16 03 2020
pubmed: 29 3 2020
medline: 27 10 2020
entrez: 29 3 2020
Statut: ppublish

Résumé

A solitary fibrous tumor (SFT) is a rare, NAB2-STAT6 fusion gene-associated mesenchymal neoplasm. It most commonly arises in the pleural site, but it can occur at many other sites, and rarely also in the head and neck (H&N) region. STFs may show many growth patterns and therefore can be easily mistaken for other more common H&N spindle cell or epithelial lesions. In this study, we present our experience in the diagnosis of 20 cases of SFT in the H&N region and discuss their most notable mimickers. In all cases, STAT6 expression was found positive by immunohistochemistry, and the NAB2-STAT6 fusion was confirmed by next-generation sequencing. Three major fusion variants were detected: NAB2ex2-STAT6int1 (5/20, 25%), NAB2ex6-STAT6ex16 (4/20, 20%), and NAB2ex4-STAT6ex2 (3/20, 15%). Clinical follow-up was available for 16 patients (median follow-up time: 84 months). One patient with a morphologically malignant SFT experienced multiple local recurrences, followed by dissemination into the lungs and meninges. This malignant SFT also displayed an aberrant FLI1 expression, which was not previously reported in SFT cases. We also summarize findings from 200 cases of SFT of the H&N region, which included cases from our study, and from previous studies that reported on the fusion status of the STAT6 gene. The results suggest that metastatic disease developed only in cases with STAT6 variants that included the DNA-binding domain (STAT6-full variants), which contradicts expectations from previous reports and deserves further investigation.

Identifiants

pubmed: 32217090
pii: S0046-8177(20)30056-3
doi: 10.1016/j.humpath.2020.03.007
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
FLII protein, human 0
Microfilament Proteins 0
NAB2 protein, human 0
Repressor Proteins 0
STAT6 Transcription Factor 0
STAT6 protein, human 0
Trans-Activators 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-12

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Martina Baněčková (M)

Department of Pathology, Charles University, The Faculty of Medicine and Faculty Hospital in Pilsen, Alej Svobody 80, Pilsen, 304 60, Czech Republic; Bioptická laboratoř s.r.o., Mikulášske nám. 4, Pilsen, 326 00, Czech Republic.

Petr Martínek (P)

Bioptická laboratoř s.r.o., Mikulášske nám. 4, Pilsen, 326 00, Czech Republic.

Alena Skálová (A)

Department of Pathology, Charles University, The Faculty of Medicine and Faculty Hospital in Pilsen, Alej Svobody 80, Pilsen, 304 60, Czech Republic; Bioptická laboratoř s.r.o., Mikulášske nám. 4, Pilsen, 326 00, Czech Republic.

Roman Mezencev (R)

School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, 30332, USA.

Ladislav Hadravský (L)

Department of Pathology, First Faculty of Medicine, Charles University, General University Hospital in Prague, Studničkova 2, Prague, 128 00, Czech Republic.

Michal Michal (M)

Department of Pathology, Charles University, The Faculty of Medicine and Faculty Hospital in Pilsen, Alej Svobody 80, Pilsen, 304 60, Czech Republic; Bioptická laboratoř s.r.o., Mikulášske nám. 4, Pilsen, 326 00, Czech Republic.

Marián Švajdler (M)

Department of Pathology, Charles University, The Faculty of Medicine and Faculty Hospital in Pilsen, Alej Svobody 80, Pilsen, 304 60, Czech Republic; Bioptická laboratoř s.r.o., Mikulášske nám. 4, Pilsen, 326 00, Czech Republic. Electronic address: svajdler@yahoo.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH